BioMaxima S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, sales was PLN 130.52 million compared to PLN 56.03 million a year ago. Net income was PLN 28.57 million compared to PLN 8.25 million a year ago. Basic earnings per share from continuing operations was PLN 6.6 compared to PLN 1.91 a year ago. Diluted earnings per share from continuing operations was PLN 6.41 compared to PLN 1.84 a year ago.